These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 35301053)

  • 1. Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy.
    Liu JQ; Zhang C; Zhang X; Yan J; Zeng C; Talebian F; Lynch K; Zhao W; Hou X; Du S; Kang DD; Deng B; McComb DW; Bai XF; Dong Y
    J Control Release; 2022 May; 345():306-313. PubMed ID: 35301053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy.
    Jiang Y; Zhang Y; Liu C; Liu J; Xue W; Wang Z; Li X
    J Control Release; 2024 Apr; 368():663-675. PubMed ID: 38492862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Tailored Ionizable Lipid Nanoparticles Facilitate IL-12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy.
    Xu S; Xu Y; Solek NC; Chen J; Gong F; Varley AJ; Golubovic A; Pan A; Dong S; Zheng G; Li B
    Adv Mater; 2024 Jul; 36(29):e2400307. PubMed ID: 38657273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
    Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
    Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
    Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral IL-12 and TNF-alpha-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity.
    Sabel MS; Skitzki J; Stoolman L; Egilmez NK; Mathiowitz E; Bailey N; Chang WJ; Chang AE
    Ann Surg Oncol; 2004 Feb; 11(2):147-56. PubMed ID: 14761917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors.
    Tähtinen S; Kaikkonen S; Merisalo-Soikkeli M; Grönberg-Vähä-Koskela S; Kanerva A; Parviainen S; Vähä-Koskela M; Hemminki A
    PLoS One; 2015; 10(6):e0131242. PubMed ID: 26107883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
    Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
    J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
    Aste-Amezaga M; D'Andrea A; Kubin M; Trinchieri G
    Cell Immunol; 1994 Jul; 156(2):480-92. PubMed ID: 7912999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat.
    Jean WC; Spellman SR; Wallenfriedman MA; Flores CT; Kurtz BP; Hall WA; Low WC
    J Neurooncol; 2004 Jan; 66(1-2):39-49. PubMed ID: 15015768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an extended half-life GM-CSF fusion protein for Parkinson's disease.
    Yeapuri P; Olson KE; Lu Y; Abdelmoaty MM; Namminga KL; Markovic M; Machhi J; Mosley RL; Gendelman HE
    J Control Release; 2022 Aug; 348():951-965. PubMed ID: 35738463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity.
    Li Y; Su Z; Zhao W; Zhang X; Momin N; Zhang C; Wittrup KD; Dong Y; Irvine DJ; Weiss R
    Nat Cancer; 2020 Sep; 1(9):882-893. PubMed ID: 34447945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.
    Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB
    Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects.
    Tian H; Shi G; Yang G; Zhang J; Li Y; Du T; Wang J; Xu F; Cheng L; Zhang X; Dai L; Chen X; Zhang S; Yang Y; Yu D; Wei Y; Deng H
    BMC Cancer; 2014 Jan; 14():48. PubMed ID: 24475975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy.
    Kim J; Song S; Gwak M; Cho H; Yun WS; Hwang N; Kim J; Lee JS; Kim DH; Kim H; Jeon SI; Kim TI; Kim K
    Biomater Res; 2023 Oct; 27(1):102. PubMed ID: 37845762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy.
    Oh E; Oh JE; Hong J; Chung Y; Lee Y; Park KD; Kim S; Yun CO
    J Control Release; 2017 Aug; 259():115-127. PubMed ID: 28336378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors.
    Chang CJ; Chen YH; Huang KW; Cheng HW; Chan SF; Tai KF; Hwang LH
    Hepatology; 2007 Mar; 45(3):746-54. PubMed ID: 17326190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
    Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
    Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of mRNA Encoding Interleukin-12 and a Stimulator of Interferon Genes Agonist Potentiates Antitumor Efficacy through Reversing T Cell Exhaustion.
    Wang B; Tang M; Chen Q; Ho W; Teng Y; Xiong X; Jia Z; Li X; Xu X; Zhang XQ
    ACS Nano; 2024 Jun; 18(24):15499-15516. PubMed ID: 38832815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.